An organ is removed from the body of the donor, transported, and then transplanted into a recipient body while kept in good condition and without severe damage. Hypothermia-induced organ cooling may aid in preservation; however, different body organs require specific and suitable storage settings to preserve their morphological and physiological functions.

In 2021, the market for organ preservation was USD 206.89 million, and by 2030 it will reach USD 377.97 million, growing at a 6.93% CAGR during the forecast period.

The market for organ preservation is expected to expand due to the rising demand for organ transplantation procedures worldwide. The expansion of government and non-governmental organization (NGO) activities for organ donation programs worldwide is accelerating market expansion. Organ donation techniques, procedures, and technological developments will stimulate market expansion. However, the high price of organ transplantation, low public knowledge of organ donation programs, and strict laws and regulations limit the market's expansion.

Market Dynamics

Drivers

The market is growing as a result of factors like planning campaigns and running awareness initiatives to increase organ donations and transplantations procedure. The rising incidence of multi-organ failure and the nation's healthcare infrastructure will fuel the market's overall growth throughout the forecast period. Over the next years, the market will benefit from rising markets and technological advances. Furthermore, the market is expanding rapidly due to numerous government and non-government legislation and initiatives to promote organ donation.

Additionally, the market is driven by an increasing number of people donating their organs voluntarily for transplantation and research. Additional factors like enhanced R&D and significant infrastructural improvements for organ preservation significantly contribute to market expansion.

Restraints

The expensive cost of organ transplantation, the large annual disparity between the number of donated and needed organs, and the relatively low level of medical reimbursements for organ donation and transplantation are the major factors limiting market growth.

Market Segmentation

By organ type

In terms of organ type, the organ preservation market is segmented into kidneys, liver, lungs, hearts, and others. In 2021, the segment for kidneys had the largest market share. The fact that kidneys are the most frequently transplanted organs accounts for this growth. The two most frequently transplanted tissues are musculoskeletal grafts and corneal grafts. 

Due to the rise in cases requiring liver transplants, the Liver segment will grow at a 7.1% CAGR over the forecast period of 2022–2027. Hypothermia has been found to significantly reduce the amount of malondialdehyde (MDA) in the liver.

By technique

On the basis of technique, the market for organ preservation is segmented into Hypothermic Machine Perfusion, Normothermic, Machine Perfusion, Static Cold Storage Technique, and other techniques. 

In 2021, the Static Cold Storage (SCS) Techniques segment had the largest market share. The increased use of static cold storage for the preservation of kidneys and other organs is responsible for the growth of this segment. Furthermore, due to the sufficient supply of nutrition and oxygen that enables aerobic metabolism, the Normothermic Machine Perfusion segment will grow at the fastest 7.3% CAGR during the forecast period of 2022–2027. The growth of this market is further fueled by superior transplantation outcomes, reduced risk of post-transplantation side effects, and transplantation techniques using antioxidant treatments.

By region

North America contributed for 33% revenue share in 2021. The expansion of this region is due to the supportive legal foundation commanding organ donation in the United States, which is built on principles solely intended to support the region's organ transplantation system. The presence of laws such as the Uniform Anatomical Gift Act (UAGA) establishes an agreeable scheme for organ donation and organ transplantation, which may include antioxidant treatments, propelling the growth of the North American Organ Preservation Market.

Furthermore, the Asia-Pacific will have the fastest CAGR rate. This expansion is due to rising healthcare spending, increased patient awareness, and growing demand for organ transplantation techniques, which may include antioxidant treatments. The growing geriatric population and an increase in kidney and heart failure cases are propelling the Asia-Pacific Organ Preservation Market forward.

Key Players

· Dr. Franz Köhler Chemie GmbH

· Paragonix Technologies

· XVIVO Perfusion AB

· TransMedics

· Essential Pharmaceuticals, LLC

· 21st Century Medicine

· Bridge To Life Limited

· Shanghai Genext Medical Technology

· Preservation Solutions

· OrganOx Limited

· Carnamedica

· Waters Medical Systems

· Biochefa

· Transplant Biomedicals

· Avionord

· Institut Georges Lopez

· SALF.

· Organ Preservation Solutions

· Vascular Perfusion Solutions

· TX Innovations

· Global Transplant Solutions

· EBERS

In 2021, the market for organ preservation was USD 206.89 million, and by 2030 it will reach USD 377.97 million, growing at a 6.93% CAGR during the forecast period. There is a rising demand for organ preservation due to rising organ failure rates around the world, campaigns to promote organ donation, an aging population, and the presence of important companies in both developing and wealthy nations.

Related Reports:

Point of Care Diagnostics Market Report - The global point of care diagnostics market will witness a robust CAGR of 11.78%, valued at $33.12 billion in 2021, expected to appreciate and reach $90.25 billion by 2030, confirms Strategic Market Research.